🇺🇸 Hormone replacement therapy in United States
1,322 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1,322
Most-reported reactions
- Breast Cancer Female — 1,010 reports (76.4%)
- Drug Ineffective — 51 reports (3.86%)
- Headache — 41 reports (3.1%)
- Nausea — 41 reports (3.1%)
- Dizziness — 40 reports (3.03%)
- Fatigue — 39 reports (2.95%)
- Anxiety — 32 reports (2.42%)
- Asthenia — 24 reports (1.82%)
- Arthralgia — 22 reports (1.66%)
- Dyspnoea — 22 reports (1.66%)
Other Endocrinology / Women's Health approved in United States
Frequently asked questions
Is Hormone replacement therapy approved in United States?
Hormone replacement therapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Hormone replacement therapy in United States?
Faculdade de Medicina do ABC is the originator. The local marketing authorisation holder may differ — check the official source linked above.